Oragenics, Inc. Investor Relations
Investor Contact via Phone:
Brian Bohunicky
CFO
386-418-4018 Ext. 242
Contact via Email:
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
Exchanges
Continental Stock Transfer & Trust Company, Inc.
17 Battery Place
New York, NY 10004
Phone 212-509-4000
The documents contained in (or directly accessible from) this website include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about growth strategies, development of technologies, financing, operational trends, regulatory compliance and any other statements containing the words "believes", "expects", "anticipates", "plans", "estimates" and similar expressions. There are a number of important factors that could cause Oragenics' actual results to differ materially from those indicated by such forward-looking statements, including factors identified in the company's most recent Annual Report on Form 10-KSB and subsequent reports filed with the SEC. The company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made.
